Mainz Enterprise Value Over E B I T D A from 2010 to 2024
| MYNZ Stock | USD 6.79 0.53 7.24% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (0.77) | Current Value (0.81) | Quarterly Volatility 80.3077064 |
Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.1 M or Interest Expense of 419.9 K, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0 or PTB Ratio of 6.09. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.
Mainz | Enterprise Value Over E B I T D A |
Latest Mainz Biomed's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Mainz Biomed BV over the last few years. It is Mainz Biomed's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Mainz Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (129.15) | |
| Coefficient Of Variation | (62.18) | |
| Mean Deviation | 67.41 | |
| Median | (169.77) | |
| Standard Deviation | 80.31 | |
| Sample Variance | 6,449 | |
| Range | 228 | |
| R-Value | 0.70 | |
| Mean Square Error | 3,566 | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | 12.53 | |
| Total Sum of Squares | 90,291 |
Mainz Enterprise Value Over E B I T D A History
About Mainz Biomed Financial Statements
Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (0.77) | (0.81) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| IBTA | Ibotta, | |
| DTST | Data Storage Corp | |
| ESRT | Empire State Realty |
Additional Tools for Mainz Stock Analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.